Found "Health Policies": 1,061 results
Sort by
Relevance

A study of feasibility of investing and access to spirometry service in community hospitals

Spirometry is a pulmonary function test that measures the volume of air exhaled quickly and strongly to assess how well the lung works. Spirometry is a gold standard of diagnosis, which distinguishes between chronic obstructive pulmonary disease (COPD) and asthma. Spirometry, moreover, is used to monitor disease progression, follow up treatment re

Groundwork: Pre-Conditions for Successful Healthcare Priority Setting

The Groundworks Project is a dialogue set up between industry representatives and health systems representatives of LMICs spanning a timeframe of 12 months and including three workshops. The first workshop focuses on agenda setting between a core group of representatives. The second workshop takes on a national perspective and discusses the context

Cost-Effectiveness Analysis of COVID-19 Vaccine Booster Dose in the Thai Setting during the Period of Omicron Variant Predominance

The Thai government implemented COVID-19 booster vaccines to prevent morbidity and mortality during the spreading of the Omicron variant. However, little is known about which types of vaccine should be invested in as the booster dose for the Thai population. This study aims to investigate the most c

How Many People Experience Unsafe Medical Care in Thailand, and How Much Does It Cost under Universal Coverage Scheme?

Adverse events and medical harm comprise major health concerns for people all over the world, including Thailand. The prevalence and burden of medical harm must always be monitored, and a voluntary database should not be used to represent national value. The purpose of this study is to estimate the

India’s Chhattisgarh state; developing a plan for Universal Health Coverage

The Indian State of Chhattisgarh is drawing up its plans to extend universal health coverage (UHC) to its people. Discussions among public health experts, practitioners, and lawmakers, therefore, turn to planning the road ahead for this state and how it can deliver on its promise. With the state at

Guest Blog: Reflections on PMAC 2020 from a Canadian Student Perspective

On January 28, 2020, PMAC 2020: Accelerating the Progress Towards UHC officially started with side meetings, with one of the very first ones hosted by Health Intervention and Technology Assessment Program (HITAP), titled “Attain & Sustain Health Gains: Incorporating Value-For-Money in the Univer

PMAC 2016 Side Event (SE 026): Making decision makers accountable: better journalism – better chances of getting to Universal Health Coverage

PMAC 2016 Side Event (SE 026): Making decision makers accountable: better journalism – better chances of getting to Universal Health CoverageThis workshop will bring together journalists, bloggers and editors from around the world to share stories of reporting countries’ journey towards and efforts

Situational Analysis of infectious disease modelling (ID) in Thailand

ID modelling is a mathematical description of the spread of infection (1). Infectious disease (ID) in this study refers to common infectious diseases (whether in humans or animals), including COVID-19. ID models help provide the understanding of the disease natural history, as well as the impact of interventions (e.g., vaccination, social distancin

Preliminary recommendations on the establishment of a regional centre for infectious disease control in ASEAN

“United we stand, divided we fall” is a Thai idiom used to exemplify the importance of staying united and of teamwork and common interests. This idiom is reaffirmed in the context of the COVID-19 pandemic, shown in the global nature of catastrophe and the shared prospects of recovery. However, p

Assessing alternative measures for controlling drug prices (in Thai language)

The study suggests that the price of patented medicine in Thailand should be controlled based on equity pricing and outcome pricing. Equity pricing can be estimated from the international reference price and outcome pricing can be evaluated from therapeutic referencing or the pharmacoeconomic price. Moreover, in a case study of 7 medicines granted
10 / Page